Vikash Reebye

1.5k citations

36 papers · 805 indexed · h-index 16

Impact in

Cancer Research top 10%
- MicroRNA in disease regulation
Molecular Biology
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- RNA modifications and cancer
- RNA Research and Splicing
- Ubiquitin and proteasome pathways

Papers in

Cancer Research 10
- MicroRNA in disease regulation 8
Equine 1

Co-authors: Nagy Habib John J. Rossi Kai‐Wen Huang Pål Sætrom Paul J. Mintz Mikael H. Sodergren David C. Blakey Robert Habib
Journals: Molecular Therapy — Nucleic Acids (6 papers)Molecular Therapy (4 papers)Oncogene (3 papers)Cellular Signalling (3 papers)Cancer Research (3 papers)
Partner nations: United Kingdom United States Taiwan

In The Last Decade

Vikash Reebye

34 papers receiving 794 citations

Peers

Countries citing papers authored by Vikash Reebye

Since Specialization

Citations

This map shows the geographic impact of Vikash Reebye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikash Reebye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikash Reebye more than expected).

Fields of papers citing papers by Vikash Reebye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikash Reebye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikash Reebye. The network helps show where Vikash Reebye may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Vikash Reebye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vikash Reebye Line = papers co-authored together Vikash Reebye links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	RNA activation of CEBPA improves leukemia treatment Molecular Therapy — Nucleic Acids ·P. Zh. Baimatov, Petra Engberg, 新斌储, Vikash Reebye, Bríd M. Ryan, (unknown), (unknown), Nathan W. Luedtke, François Mercier, Maureen McKeague	2025	0
2	Design and Evaluation of RNA Aptamer–Mediated Delivery of C/EBP β siRNA for Oncological Therapy Journal of Nucleic Acids ·Daniel Vasconcelos, Mikael H. Sodergren, Vikash Reebye, He Jinbin, Manshu Song, Katharine Nichole Holm, Shirin Elizabeth Khorsandi, John J. Rossi, Nagy Habib, Kai‐Wen Huang	2025	0
3	Enhancing SIRT1 Gene Expression Using Small Activating RNAs: A Novel Approach for Reversing Metabolic Syndrome Nucleic Acid Therapeutics ·Pinelopi Andrikakou, Vikash Reebye, Daniel Vasconcelos, Sorah Yoon, Jon Voutila, Andrew J.T. George, Piotr Swiderski, Robert Habib, Matthew C. Catley, David C. Blakey, Nagy Habib, John J. Rossi, Kai‐Wen Huang	2022	11
4	Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC Molecular Therapy — Nucleic Acids ·Sorah Yoon, Kai‐Wen Huang, Pinelopi Andrikakou, Daniel Vasconcelos, Piotr Swiderski, Vikash Reebye, Mikael H. Sodergren, Nagy Habib, John J. Rossi	2019	28
5	Liver Activation of Hepatocellular Nuclear Factor-4α by Small Activating RNA Rescues Dyslipidemia and Improves Metabolic Profile Molecular Therapy — Nucleic Acids ·Kai‐Wen Huang, Vikash Reebye, ヨシタカサトウ, حسام حرجان عجاج العيساوي, Stephanie Dorman, Isabella Reccia, Hong‐Shiee Lai, Ling Peng, Ruth Beale, Joanna P. Nicholls, W. Malsch, Donald A. Tomalia, Pål Sætrom, Edmund H. Wilkes, Pedro R. Cutillas, John J. Rossi, Nagy Habib	2019	54
6	Mechanisms involved in the activation of C/EBPα by small activating RNA in hepatocellular carcinoma Oncogene ·Xiaoyang Zhao, Vikash Reebye, Paul G. Hitchen, Jia Fan, Hongchi Jiang, Pål Sætrom, John J. Rossi, Nagy Habib, Kai‐Wen Huang	2019	29
7	Abstract 3856: MTLCEBPA, a drug candidate for hepatocellular-carcinoma enhances efficacy of Sorafenib Cancer Research ·Nagy Habib, Kai‐Wen Huang, Vikash Reebye, Mikael H. Sodergren, John J. Rossi	2019	1
8	Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized Mice Molecular Therapy ·Jiehua Zhou, Haitang Li, Marco Lilla, Alberto Herrera, QI Hai-quan, Vikash Reebye, Mikael H. Sodergren, Stephanie Dorman, Bruce H. Littman, 洪雪娥, Kai‐Wen Huang, Robert Habib, David C. Blakey, Nagy Habib, John J. Rossi	2019	28
9	Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer Oncogene ·Vikash Reebye, Kai‐Wen Huang, Vivian Lin, Sheba Jarvis, Rattanachart Sirinil, Stephanie Dorman, حسام حرجان عجاج العيساوي, Pinelopi Andrikakou, Jon Voutila, Pål Sætrom, Paul J. Mintz, Isabella Reccia, John J. Rossi, Hans E. Huber, Robert Habib, Ruth Beale, David C. Blakey, Nagy Habib	2018	73
10	Treatment of Liver Cancer by C/EBPA saRNA Advances in experimental medicine and biology ·Xiaoyang Zhao, Jon Voutila, Alexandra Kanygina, Nagy Habib, Vikash Reebye	2017	9
11	Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer Molecular Therapy ·Jon Voutila, Vikash Reebye, Thomas C. Roberts, Nolan Swain, Pinelopi Andrikakou, David C. Blakey, Robert Habib, Hans E. Huber, Pål Sætrom, John J. Rossi, Nagy Habib	2017	85
12	Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo Molecular Therapy ·Sorah Yoon, Kai‐Wen Huang, Vikash Reebye, Paul J. Mintz, Yu‐Wen Tien, Hong‐Shiee Lai, Pål Sætrom, Isabella Reccia, Piotr Swiderski, Brian Armstrong, G.H. Sahasrabudhe, Duncan Spalding, Long R. Jiao, Nagy Habib, John J. Rossi	2016	61
13	Aptamer-Drug Conjugates of Active Metabolites of Nucleoside Analogs and Cytotoxic Agents Inhibit Pancreatic Tumor Cell Growth Molecular Therapy — Nucleic Acids ·Sorah Yoon, Kai‐Wen Huang, Vikash Reebye, Duncan Spalding, Teresa M. Przytycka, J. Forbes, Piotr Swiderski, Lin Li, Brian Armstrong, Isabella Reccia, Dimitris Zacharoulis, Konstantinos Dimas, Tomokazu Kusano, John E. Shively, Nagy Habib, John J. Rossi	2016	68
14	The functional role of C/EBPα and C/EBPβ in hepatocellular carcinoma (HCC) HPB ·Xiaoyang Zhao, Nagy Habib, Vikash Reebye	2016	1
15	A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34+ Cells Molecular Therapy — Nucleic Acids ·Vikash Reebye, Pål Sætrom, Paul J. Mintz, John J. Rossi, Noriyuki Kasahara, Georgios Nteliopoulos, Joanna P. Nicholls, Abdelali Haoudi, Myrtle Y. Gordon, Nagy Habib	2013	10
16	Exploiting Human CD34+ Stem Cell–conditioned Medium for Tissue Repair Molecular Therapy ·Paul J. Mintz, Kai‐Wen Huang, Vikash Reebye, Georgios Nteliopoulos, Hong‐Shiee Lai, Pål Sætrom, Noriyuki Kasahara, S L Jensen, Madhava Pai, Myrtle Y. Gordon, Stephen B. Marley, Amandine Labat, Duncan Spalding, Abdelali Haoudi, Mohamed M. Emara, Joanna P. Nicholls, John J. Rossi, Nagy Habib	2013	10
17	MicroRNA-181a* Targets Nanog in a Subpopulation of CD34+ Cells Isolated From Peripheral Blood Molecular Therapy — Nucleic Acids ·Paul J. Mintz, Pål Sætrom, Vikash Reebye, Александр Яковлевич Кодинцев, Kaiqin Lao, John J. Rossi, Karin Gaensler, Noriyuki Kasahara, Joanna P. Nicholls, S L Jensen, Abdelali Haoudi, Mohamed M. Emara, Myrtle Y. Gordon, Nagy Habib	2012	13
18	A perspective on non-catalytic Src homology (SH) adaptor signalling proteins Cellular Signalling ·Vikash Reebye, Andrea Frilling, Amin Hajitou, Joanna P. Nicholls, Nagy Habib, Paul J. Mintz	2011	17
19	Intracellular adaptor molecules and AR signalling in the tumour microenvironment Cellular Signalling ·Vikash Reebye, Andrea Frilling, Nagy Habib, Paul J. Mintz	2010	16
20	Mechanisms of androgen receptor repression in prostate cancer Biochemical Society Transactions ·Sue M. Powell, Greg N. Brooke, Hayley C. Whitaker, Vikash Reebye, Simon C. Gamble, Jorge Manuel Moura Loureiro de Miranda, D. Alwyn Dart, Borja Belandia, Charlotte L. Bevan	2006	15

About Vikash Reebye

Vikash Reebye is a scholar working on Cancer Research, Equine, Hepatology, Transplantation and Endocrinology, Diabetes and Metabolism, having authored 36 papers that have together received 805 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers), Estrogen and related hormone effects (4 papers), Prostate Cancer Treatment and Research (4 papers), Hormonal and reproductive studies (3 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Cancer Research (184 citations), Molecular Biology (549 citations), Hepatology (31 citations), Immunology (80 citations) and Pharmacology (61 citations). Vikash Reebye has collaborated with scholars based in United Kingdom, United States and Taiwan. Frequent co-authors include Nagy Habib, John J. Rossi, Kai‐Wen Huang, Pål Sætrom, Paul J. Mintz, Mikael H. Sodergren, David C. Blakey, Robert Habib, Pinelopi Andrikakou and Isabella Reccia. Their work appears in journals such as Molecular Therapy — Nucleic Acids, Molecular Therapy, Oncogene, Cellular Signalling and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact